Oncocross Co., Ltd. (KOSDAQ:382150)
South Korea · Delayed Price · Currency is KRW 8,970.00
+100.00 (1.13%)
Oct 10, 2025, 3:30 PM KST
Oncocross Market Cap
Oncocross has a market cap or net worth of 107.80 billion as of October 10, 2025.
Market Cap
107.80B
Enterprise Value
91.84B
Revenue
1.04B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,970.00
Market Cap Chart
Since December 18, 2024, Oncocross's market cap has increased from 106.25B to 107.80B, an increase of 1.46%. That is a compound annual growth rate of 1.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 107.80B | 43.39% |
| Dec 30, 2024 | 75.18B | -29.24% |
| Dec 18, 2024 | 106.25B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |